Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia

Molecular Therapy(2023)10.1016/j.ymthe.2023.06.020Source: DataRank Database

Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia is a research paper published in Molecular Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.38)OA: hybridTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Felix Englmaier,Pauline Morigny ORCID,Maude Giroud ORCID,Pamina Gräsle,Sebastian Brings ORCID

Live enrichment

PubMed:37408309 PMC:PMC10422018 OpenAlex:https://openalex.org/W4383092708

National Institutes of Health

Grant: R01-GM129325

HORIZON EUROPE European Research Council

Grant: 949017

Targeting the crosstalk of lipid and glucose metabolism to stop cancer-associated wasting

NIGMS NIH HHS

Grant: R01 GM129325

National Institutes of Health

Grant: 5R01GM129325-08

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling

European Research Council

Helmholtz Association

National Institute of Allergy and Infectious Diseases

Novo Nordisk

Horizon 2020

Alexander von Humboldt-Stiftung

Horizon 2020 Framework Programme

FWCI

1.38

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ymthe.2023.06.020

publisherhttps://doi.org/10.1016/j.ymthe.2023.06.020

publisherhttps://api.elsevier.com/content/article/PII:S1525001623003805?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001623003805?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37408309

Fields of Study

Muscle Physiology and DisordersVirus-based gene therapy researchAdipose Tissue and MetabolismAnimalsHumansAdipose TissueAMP-Activated Protein KinasesCachexiaNeoplasmsPeptidesPharmaceutical PreparationsQuality of Life

MeSH Terms

Adipose TissueAnimalsCachexiaPharmaceutical PreparationsHumansNeoplasmsPeptidesQuality of LifeAMP-Activated Protein Kinases

Keywords

CachexiaAdipose tissueAMPKCancer researchMedicineCancerLipolysisInternal medicineEndocrinologyProtein kinase ABiologyKinaseCell biologyMetabolic DysfunctionPeptide-drugAMP-Activated Protein KinasesAdipose Tissue ; Ampk ; Cachexia ; Cancer ; Metabolic Dysfunction ; Peptide-drugPharmaceutical PreparationsNeoplasmsQuality of LifeAnimalsHumansOriginal ArticleDewey Decimal Classification::600 | Technik::610 | Medizin, GesundheitPeptides

Sustainable Development Goals

SDG 0: Good health and well-being

Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia

FAIR Checklist

Authors (11)

Funding (11 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)